Histopathological features of endometrial carcinomas associated withPOLEmutations: implications for decisions about adjuvant therapy

A clinically applicable molecular-based classification for endometrial cancers

(2015) A Talhouk et al.   BRITISH JOURNAL OF CANCER

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

(2015) I. C. van Gool et al.   CLINICAL CANCER RESEARCH

Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas

(2015) M.K. McConechy et al.   GYNECOLOGIC ONCOLOGY

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

(2015) Ellen Stelloo et al.   MODERN PATHOLOGY

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

(2015) Dung T. Le et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing

(2014) Caroline C. Billingsley et al.   CANCER

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium

(2014) Bo Meng et al.   GYNECOLOGIC ONCOLOGY

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

(2014) David N. Church et al.   JNCI-Journal of the National Cancer Institute

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

(2014) Yaser R Hussein et al.   MODERN PATHOLOGY

Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas

(2013) Lien N. Hoang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry

(2013) Martin Köbel et al.   HISTOPATHOLOGY

DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer

(2013) David N. Church et al.   HUMAN MOLECULAR GENETICS

Reproducibility of histological cell type in high-grade endometrial carcinoma

(2013) Guangming Han et al.   MODERN PATHOLOGY

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas

(2010) Martin Köbel et al.   JOURNAL OF PATHOLOGY

Endometrial carcinomas with ambiguous features

(2010) Robert A. Soslow   SEMINARS IN DIAGNOSTIC PATHOLOGY

Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer

(2007) Jinru Shia et al.   HUMAN PATHOLOGY